Hemochromatosis: diagnosis and management

Area of Science:

• Genetics and Metabolism
• Gastroenterology and Hepatology
• Cardiology

Background:

• Hemochromatosis is a common autosomal recessive disorder affecting iron metabolism.
• It leads to progressive organ damage, particularly in the liver, pancreas, and heart.
• The condition is more prevalent in males and individuals of white ethnicity.

Observation:

• Clinical presentation is often nonspecific, necessitating a high index of suspicion.
• Abnormal iron studies, including elevated serum ferritin and transferrin saturation, suggest the diagnosis.
• Symptoms may include diabetes mellitus, hepatic dysfunction, and congestive heart failure.

Findings:

• Liver biopsy can confirm hemochromatosis and assess for cirrhosis.
• Magnetic resonance imaging (MRI) may reveal characteristic iron deposition.
• A diagnostic response to phlebotomy, indicated by a rapidly normalizing hematocrit, supports the diagnosis.

Implications:

• Phlebotomy effectively reduces total body iron, preventing further organ damage.
• Timely treatment mitigates premature morbidity and mortality associated with hemochromatosis.
• Screening in affected families is recommended, with broader population screening under evaluation.